FDA Import Refusal BDD-0882245-0/111/1 — Sanofi Aventis
The FDA refused shipment BDD-0882245-0/111/1 from Sanofi Aventis (Philippines) on May 25, 2021. The refused product falls under Drugs and Biologics — ANTI-INFECTIVE, TOPICAL N.E.C.. Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- May 25, 2021
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 62FBL99 ANTI-INFECTIVE, TOPICAL N.E.C.
- Charges
- 118,3280